These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 15382304

  • 1. Current state of imaging for lung cancer staging.
    Kent MS, Port JL, Altorki NK.
    Thorac Surg Clin; 2004 Feb; 14(1):1-13. PubMed ID: 15382304
    [Abstract] [Full Text] [Related]

  • 2. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
    Truong MT, Munden RF, Movsas B.
    J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
    [Abstract] [Full Text] [Related]

  • 3. Imaging of pleural and chest wall tumors.
    Weyant MJ, Flores RM.
    Thorac Surg Clin; 2004 Feb; 14(1):15-23. PubMed ID: 15382305
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy.
    Alvarez JM, Hasani A, Segal A, Sterret G, Millward M, Nowak A, Musk W, Bydder S.
    ANZ J Surg; 2009 Oct; 79(10):734-8. PubMed ID: 19878170
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.
    Annema JT, Hoekstra OS, Smit EF, Veseliç M, Versteegh MI, Rabe KF.
    Lung Cancer; 2004 Apr; 44(1):53-60. PubMed ID: 15013583
    [Abstract] [Full Text] [Related]

  • 9. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
    Ohtsuka T, Nomori H, Ebihara A, Watanabe K, Kaji M, Naruke T, Suemasu K, Uno K.
    Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
    [Abstract] [Full Text] [Related]

  • 10. [Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients].
    Prévost A, Papathanassiou D, Jovenin N, Menéroux B, Cuif-Job A, Bruna-Muraille C, Domange-Testard A, Liehn JC.
    Rev Pneumol Clin; 2009 Dec; 65(6):341-9. PubMed ID: 19995654
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
    Pöpperl G, Lang S, Dagdelen O, Jäger L, Tiling R, Hahn K, Tatsch K.
    Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
    [Abstract] [Full Text] [Related]

  • 13. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
    Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, Fillet G.
    Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273
    [Abstract] [Full Text] [Related]

  • 14. Noninvasive staging of lung cancer.
    Misciasci T.
    Rays; 2004 Mar; 29(4):363-71. PubMed ID: 15852721
    [Abstract] [Full Text] [Related]

  • 15. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
    Quaia E, Tona G, Gelain F, Lubin E, Pizzolato R, Boscolo E, Bussoli L.
    Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
    [Abstract] [Full Text] [Related]

  • 16. Staging techniques for lung cancer.
    Lau CL, Harpole DH, Patz E.
    Chest Surg Clin N Am; 2000 Nov; 10(4):781-801. PubMed ID: 11091926
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
    D'Cunha J, Herndon JE, Herzan DL, Patterson GA, Kohman LJ, Harpole DH, Kernstine KH, Kern JA, Green MR, Maddaus MA, Kratzke RA, Cancer and Leukemia Group B.
    Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP, Kramer H, Reiser MF, Glaser C.
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.